Evidence map›Paper›PMID 35203295›Full record

ArticleCells2022

Label-Free Digital Holographic Microscopy for In Vitro Cytotoxic Effect Quantification of Organic Nanoparticles.

Kai Moritz Eder, Anne Marzi, Álvaro Barroso, Steffi Ketelhut, Björn Kemper, Jürgen Schnekenburger

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai Moritz EderBiomedical Technology Center, University of Muenster, Mendelstraße 17, D-48149 Muenster, Germany.ORCID 0000-0003-1646-8129
Anne MarziBiomedical Technology Center, University of Muenster, Mendelstraße 17, D-48149 Muenster, Germany.
Álvaro BarrosoBiomedical Technology Center, University of Muenster, Mendelstraße 17, D-48149 Muenster, Germany.
Steffi KetelhutBiomedical Technology Center, University of Muenster, Mendelstraße 17, D-48149 Muenster, Germany.
Björn KemperBiomedical Technology Center, University of Muenster, Mendelstraße 17, D-48149 Muenster, Germany.ORCID 0000-0003-3693-9397
Jürgen SchnekenburgerBiomedical Technology Center, University of Muenster, Mendelstraße 17, D-48149 Muenster, Germany.ORCID 0000-0002-0199-2908

Funding

European Union Grant agreement ID 761104German Federal Ministry of Education and Research FKZ 03XP0213D
6 · The paper itself

Abstract

Cytotoxicity quantification of nanoparticles is commonly performed by biochemical assays to evaluate their biocompatibility and safety. We explored quantitative phase imaging (QPI) with digital holographic microscopy (DHM) as a time-resolved in vitro assay to quantify effects caused by three different types of organic nanoparticles in development for medical use. Label-free proliferation quantification of native cell populations facilitates cytotoxicity testing in biomedical nanotechnology. Therefore, DHM quantitative phase images from measurements on nanomaterial and control agent incubated cells were acquired over 24 h, from which the temporal course of the cellular dry mass was calculated within the observed field of view. The impact of LipImage™ 815 lipidots

Indexed as

HolographyNanoparticlesBiological AssayCell LineMicroscopycell culturecytotoxicitydigital holographic microscopy quantitative phase imagingdry massin vitronanoparticlesWST-8 cell viability assay

Identifiers

PMID35203295
PMCPMC8870653
OpenAlexW4212851475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.